COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,351 Articles (22,803 medRxiv, 8,548 bioRxiv)

Most recent first Previous |  Page 1386: Articles 13851-13860  | Next

Conversion rate to the secondary conformation state in the binding mode of SARS-CoV-2 spike protein to human ACE2 may predict infectivity efficacy of the underlying virus mutant
Sevenich, M., van den Heuvel, J., Gering, I., Mohrlueder, J., Willbold, D.
10.1101/2021.07.14.452313 — Posted: 2021-07-14
Water-soluble tocopherol derivatives inhibit SARS-CoV-2 RNA-dependent RNA polymerase
Pacl, H. T., Tipper, J. L., Sevalkar, R. R., Crouse, A., Crowder, C., UAB Precision Medicine Institute, , Holder, G. D., Kuhlman, C. J., Chinta, K. C., Nadeem, S., Green, T. J., Petit, C. M., Steyn, A. J., Might, M., Harrod, K. S.
10.1101/2021.07.13.449251 — Posted: 2021-07-14
Repurposing screen highlights broad-spectrum coronavirus antivirals and their host targets
Haid, S., Matthaei, A., Winkler, M., Sake, S. M., Gunesch, A. P., Rueckert, J., Vieyres, G., Kuehl, D., Nguyen, T.-T., Lasswitz, L., Zapatero, F., Brogden, G., Gerold, G., Wiegmann, B., Bilitewski, U., Broenstrup, M., Schulz, T., Pietschmann, T.
10.1101/2021.07.14.452343 — Posted: 2021-07-14
Xeno-nucleic Acid (XNA) 2'-Fluoro-Arabino Nucleic Acid (FANA) Aptamers to the Receptor Binding Domain of SARS-CoV-2 S Protein Block ACE2 Binding
Alves Ferreira-Bravo, I., DeStefano, J. J.
10.1101/2021.07.13.452259 — Posted: 2021-07-14
A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primates
Dalvie, N. C., Tostanoski, L. H., Rodriguez-Aponte, S. A., Kaur, K., Bajoria, S., Kumru, O., Martinot, A. J., Chandrashekar, A., McMahan, K., Mercado, N. B., Yu, J., Chang, A., Giffin, V. M., Nampanya, F., Patel, S., Bowman, L., Naranjo, C. A., Yun, D., Flinchbaugh, Z., Pessaint, L., Brown, R., Velasco, J., Teow, E., Cook, A., Andersen, H., Lewis, M. G., Camp, D. L., Silverman, J. M., Kleanthous, H., Joshi, S. B., Volkin, D. B., Biswas, S., Love, J. C., Barouch, D. H.
10.1101/2021.07.13.452251 — Posted: 2021-07-14
hnRNPA1 regulates early translation to replication switch in SARS-CoV-2 life cycle
Kumar, R., Chander, Y., Khandelwal, N., Nagori, H., Verma, A., Pal, Y., Gulati, B. R., Tripathi, B. N., Barua, S., Kumar, N.
10.1101/2021.07.13.452288 — Posted: 2021-07-14
Adaptation, spread and transmission of SARS-CoV-2 in farmed minks and related humans in the Netherlands
Lu, L., Sikkema, R. S., Velkers, F. C., Nieuwenhuijse, D. F., Fischer, E. A. J., Meijer, P. A., Bouwmeester-Vincken, N., Rietveld, A., Wegdam-Blans, M. C. A., Tolsma, P., Koppelman, M., Smit, L. A. M., Hakze-van der Honing, R. W., van der Poel, W. H. M., van der Spek, A. N., Spierenburg, M. A. H., Molenaar, R. J., de Rond, J., Augustijn, M., Woolhouse, M., Stegeman, A. J., Lycett, S., Oude Munnink, B. B., Koppelman, M. P. G.
10.1101/2021.07.13.452160 — Posted: 2021-07-14
Tissue Specific Age Dependence of the Cell Receptors Involved in the SARS-CoV-2 Infection
Forst, C. V., Zeng, L., Wang, Q., Zhou, X., Vatansever, S., Tu, Z., Zhang, B.
10.1101/2021.07.13.452256 — Posted: 2021-07-14
Use of 1-MNA to Improve Exercise Tolerance and Fatigue in Patients After COVID-19
Chudzik, M., Kapusta, J., Burzynska, M.
10.1101/2021.07.14.21259081 — Posted: 2021-07-14
Vaccine serologic responses among transplant patients associate with COVID-19 infection and T peripheral helper cells
Lemieux, J. E., Li, A., Gentili, M., Perugino, C. A., Weiss, Z. F., Bowman, K., Ankomah, P., Liu, H., Lewis, G. D., Bitar, N., Lipiner, T., Hacohen, N., Pillai, S. S., Goldberg, M. B.
10.1101/2021.07.11.21260338 — Posted: 2021-07-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).